These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12403928)

  • 1. Role of CD83 in the immunomodulation of dendritic cells.
    Lechmann M; Zinser E; Golka A; Steinkasserer A
    Int Arch Allergy Immunol; 2002 Oct; 129(2):113-8. PubMed ID: 12403928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction between dendritic cells and herpes simplex virus-1.
    Kobelt D; Lechmann M; Steinkasserer A
    Curr Top Microbiol Immunol; 2003; 276():145-61. PubMed ID: 12797447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD83: a regulatory molecule of the immune system with great potential for therapeutic application.
    Fujimoto Y; Tedder TF
    J Med Dent Sci; 2006 Jun; 53(2):85-91. PubMed ID: 16913569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD83 on dendritic cells: more than just a marker for maturation.
    Lechmann M; Berchtold S; Hauber J; Steinkasserer A
    Trends Immunol; 2002 Jun; 23(6):273-5. PubMed ID: 12072358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD83 Antibody Inhibits Human B Cell Responses to Antigen as well as Dendritic Cell-Mediated CD4 T Cell Responses.
    Wong KY; Baron R; Seldon TA; Jones ML; Rice AM; Munster DJ
    J Immunol; 2018 May; 200(10):3383-3396. PubMed ID: 29643191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-bound and soluble porcine CD83 functions antithetically in T cell activation and dendritic cell differentiation in vitro.
    Huo S; Zhang J; Liang S; Wu F; Zuo Y; Cui D; Zhang Y; Zhong Z; Zhong F
    Dev Comp Immunol; 2019 Oct; 99():103398. PubMed ID: 31121186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells.
    Lechmann M; Krooshoop DJ; Dudziak D; Kremmer E; Kuhnt C; Figdor CG; Schuler G; Steinkasserer A
    J Exp Med; 2001 Dec; 194(12):1813-21. PubMed ID: 11748282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced activation of CD83-positive T cells.
    Wolenski M; Cramer SO; Ehrlich S; Steeg C; Fleischer B; von Bonin A
    Scand J Immunol; 2003 Sep; 58(3):306-11. PubMed ID: 12950676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD83 expression is a sensitive marker of activation required for B cell and CD4+ T cell longevity in vivo.
    Prazma CM; Yazawa N; Fujimoto Y; Fujimoto M; Tedder TF
    J Immunol; 2007 Oct; 179(7):4550-62. PubMed ID: 17878352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD83 regulates lymphocyte maturation, activation and homeostasis.
    Breloer M; Fleischer B
    Trends Immunol; 2008 Apr; 29(4):186-94. PubMed ID: 18329338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity.
    Kruse M; Rosorius O; Krätzer F; Stelz G; Kuhnt C; Schuler G; Hauber J; Steinkasserer A
    J Virol; 2000 Aug; 74(15):7127-36. PubMed ID: 10888653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD83 Modulates B Cell Activation and Germinal Center Responses.
    Krzyzak L; Seitz C; Urbat A; Hutzler S; Ostalecki C; Gläsner J; Hiergeist A; Gessner A; Winkler TH; Steinkasserer A; Nitschke L
    J Immunol; 2016 May; 196(9):3581-94. PubMed ID: 26983787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct contact of platelets and their released products exert different effects on human dendritic cell maturation.
    Hamzeh-Cognasse H; Cognasse F; Palle S; Chavarin P; Olivier T; Delézay O; Pozzetto B; Garraud O
    BMC Immunol; 2008 Sep; 9():54. PubMed ID: 18817542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic expression of a CD83-immunoglobulin fusion protein impairs the development of immune-competent CD4-positive T cells.
    Lüthje K; Cramer SO; Ehrlich S; Veit A; Steeg C; Fleischer B; Bonin Av; Breloer M
    Eur J Immunol; 2006 Aug; 36(8):2035-45. PubMed ID: 16841299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous CD83 Expression in CD4
    Liedtke K; Alter C; Günther A; Hövelmeyer N; Klopfleisch R; Naumann R; Wunderlich FT; Buer J; Westendorf AM; Hansen W
    J Immunol; 2020 Jun; 204(12):3217-3226. PubMed ID: 32341061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD83 knockdown in monocyte-derived dendritic cells by small interfering RNA leads to a diminished T cell stimulation.
    Prechtel AT; Turza NM; Theodoridis AA; Steinkasserer A
    J Immunol; 2007 May; 178(9):5454-64. PubMed ID: 17442926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L Particles Transmit Viral Proteins from Herpes Simplex Virus 1-Infected Mature Dendritic Cells to Uninfected Bystander Cells, Inducing CD83 Downmodulation.
    Heilingloh CS; Kummer M; Mühl-Zürbes P; Drassner C; Daniel C; Klewer M; Steinkasserer A
    J Virol; 2015 Nov; 89(21):11046-55. PubMed ID: 26311871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus type 1 ICP0 induces CD83 degradation in mature dendritic cells independent of its E3 ubiquitin ligase function.
    Heilingloh CS; Mühl-Zürbes P; Steinkasserer A; Kummer M
    J Gen Virol; 2014 Jun; 95(Pt 6):1366-1375. PubMed ID: 24643878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T lymphoblasts and activated dendritic cells in the allogeneic mixed leukocyte reaction are susceptible to NK cell-mediated anti-CD83-dependent cytotoxicity.
    Munster DJ; MacDonald KP; Kato M; Hart DJ
    Int Immunol; 2004 Jan; 16(1):33-42. PubMed ID: 14688058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation.
    Seldon TA; Pryor R; Palkova A; Jones ML; Verma ND; Findova M; Braet K; Sheng Y; Fan Y; Zhou EY; Marks JD; Munro T; Mahler SM; Barnard RT; Fromm PD; Silveira PA; Elgundi Z; Ju X; Clark GJ; Bradstock KF; Munster DJ; Hart DN
    Leukemia; 2016 Mar; 30(3):692-700. PubMed ID: 26286117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.